webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Gly-NH-CH2-Boc

  CAS No.: 14664-05-2   Cat No.: BADC-01627 4.5  

Gly-NH-CH2-Boc is a Boc-protected glycine derivative ADC linker intermediate designed for site-specific payload conjugation and enhanced stability in antibody-drug conjugates. Keywords: ADC linker, glycine linker, Boc protection, payload attachment, bioconjugation.

Gly-NH-CH2-Boc

Structure of 14664-05-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C8H16N2O3
Molecular Weight
188.22

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
tert-butyl glycylglycinate; Gly-Gly-O-tBu
IUPAC Name
tert-butyl 2-[(2-aminoacetyl)amino]acetate
Canonical SMILES
CC(C)(C)OC(=O)CNC(=O)CN
InChI
InChI=1S/C8H16N2O3/c1-8(2,3)13-7(12)5-10-6(11)4-9/h4-5,9H2,1-3H3,(H,10,11)
InChIKey
VJEYRLMJNBJAHS-UHFFFAOYSA-N
Density
1.083±0.06 g/cm3
Melting Point
114-116°C
Appearance
Colorless to light yellow Oil
Boiling Point
315.5±22.0 °C at 760 mmHg

Gly-NH-CH2-Boc, also recognized as N-Boc-glycine methyl ester, stands as a versatile compound with wide-ranging applications in organic synthesis and biotechnological endeavors.

Peptide Synthesis: A staple in peptide synthesis, Gly-NH-CH2-Boc emerges as a frequently employed protected glycine derivative. The Boc (tert-butoxycarbonyl) group acts as a shield for the amino group during peptide chain elongation, averting undesired side reactions. This enables the precise and selective assembly of peptides with custom sequences and functionalities, exemplifying the finesse of organic synthesis.

Pharmaceutical Development: Pioneering drug discovery, Gly-NH-CH2-Boc plays a pivotal role as a fundamental building block for crafting biologically active molecules and pharmaceutical intermediates. Through the integration of this safeguarded amino acid into drug candidates, researchers delve into the intricate structure-activity relationships crucial for designing and enhancing novel therapeutic agents.

Bioconjugation: Embracing bioconjugation strategies, Gly-NH-CH2-Boc proves instrumental in attaching functional molecules to biomolecules like proteins or antibodies. The Boc group, known for its ease of removal under mild conditions, liberates the amino group for subsequent chemical alterations.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-N-(4-azidobutyl)glycine | Maytansine | Alkyne-Val-Cit-PAB-FAM | Adaphotris | MC-Val-Cit-PAB-carfilzomib | Idarubicin | INNO-206 | MTS-4-NHS | Patritumab deruxtecan | Azido-PEG7-amine | Gly-NH-CH2-Boc
Send Inquiry
Verification code
Inquiry Basket